PaulHarmatzMD

Pediatric Gastroenterology • Oakland, CA

Physician

Join to view full profile

Dr. Harmatz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Harmatz's full profile

Already have an account?

Office
747 52nd St
Oakland, CA 94609
Phone+1 510-428-3058

Fax+1 510-450-5813

Education & Training

Massachusetts General HospitalFellowship, Gastroenterology, 1979 - 1982
Los Angeles County-Harbor-UCLA Medical CenterResidency, Pediatrics, 1976 - 1979
Geisel School of Medicine at DartmouthClass of 1976

Certifications & Licensure

CA State Medical License 1977 - 2027
FL State Medical License 2021 - 2027
MI State Medical License 2024 - 2027
MT State Medical License 2022 - 2026
NM State Medical License 2023 - 2026
OH State Medical License 2022 - 2026
WA State Medical License 2023 - 2026
AZ State Medical License 2023 - 2025
CO State Medical License 2023 - 2025
GA State Medical License 2022 - 2025
MO State Medical License 2024 - 2025
NC State Medical License 2021 - 2025
NH State Medical License 2021 - 2025
NJ State Medical License 2024 - 2025
OR State Medical License 2024 - 2025
TX State Medical License 2021 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Gastroenterology
Join now to see all

Clinical Trials

Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment Start of enrollment: 2006 Feb 01
Completed
Phase 2
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase Start of enrollment: 2007 Jul 25
Completed
Phase 2, Phase 3
A Study of Intrathecal Enzyme Therapy for Cognitive Decline in MPS I Start of enrollment: 2009 Jun 01
Completed
Not Applicable
An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients Start of enrollment: 2008 Oct 14
Completed
Treatment Protocol of Replagal for Patients With Fabry Disease
No longer available
An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165 Start of enrollment: 2013 May 01
Completed
Phase 3
Longitudinal Studies of Brain Structure and Function in MPS Disorders Start of enrollment: 2009 Sep 01
Completed
Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment Start of enrollment: 2014 Mar 24
Completed
Phase 2, Phase 3
A Phase 3 Study of UX003 Recombinant Human Betaglucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7) Start of enrollment: 2014 Dec 01
Completed
Phase 3
A Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Therapy in Subjects With Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7) Start of enrollment: 2015 Nov 10
Completed
Phase 3
A Study to Assess the Safety and Tolerability of SOBI003 in Pediatric MPS IIIA Patients Start of enrollment: 2018 Jun 19
Completed
Phase 1, Phase 2
Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis Start of enrollment: 2021 Jan 11
Withdrawn
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
Oral Infigratinib Therapy in Children with Achondroplasia.
Ravi Savarirayan, Josep Maria De Bergua, Paul Arundel, Jean Pierre Salles, Vrinda Saraff
The New England Journal of Medicine. 2025-02-27
Prenatal Delivery of Enzyme Replacement Therapy to Fetuses Affected by Early-Onset Lysosomal Storage Diseases.
Beltran Borges, Emma Canepa, Irene J Chang, Akos Herzeg, Billie Lianoglou
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 2025-01-31
Sustained growth-promoting effects of vosoritide in children with achondroplasia from an ongoing phase 3 extension study.
Ravi Savarirayan, Melita Irving, William R Wilcox, Carlos A Bacino, Julie E Hoover-Fong
Med. 2024-12-30

Press Mentions

REGENXBIO Announces Presentations of RGX-121 at the 21st Annual WORLDSymposium 2025January 30th, 2025
Rare, Deadly Genetic Disease Successfully Treated in Utero for First TimeNovember 9th, 2022
BioMarin Announces New and Updated Data at 2021 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting Demonstrating Commitment to Understanding Achondroplasia and Potential Treatment ChoiceApril 15th, 2021
Join now to see all

PaulHarmatzMD

Dr. Harmatz is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.